NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Authorised
- Rabies virus, strain Pasteur RIV, Inactivated
- Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
- Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Product identification
Medicine name:
NOBIVAC RL ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
- Rabies virus, strain Pasteur RIV, Inactivated
- Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated
- Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain Pasteur RIV, Inactivated3.00/international unit(s)1.00millilitre(s)
-
Leptospira interrogans, serovar Copenhageni, strain 820K, Inactivated40.00/Hamster protective Dose 80%1.00millilitre(s)
-
Leptospira interrogans, serovar Portlandvere, strain Ca-12-000, Inactivated40.00/Hamster protective Dose 80%1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Intervet Hellas M.A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 27950/97/Κ2520/27-1-1998/K-0076101
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet